查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1751191

透明质酸市场规模、份额、趋势分析报告：按应用、地区和细分市场预测，2025 年至 2030 年

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

透明质酸市场成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球透明质酸市场规模预计到 2030 年将达到 167 亿美元，2025 年至 2030 年的复合年增长率为 7.81%。

人们对化学品日益增长的兴趣、对快速显着效果的渴望以及更短的恢復时间等因素，是高效渲染的驱动因素。由于已开发国家和开发中地区越来越多地采用美容手术，该行业正在快速发展。为了提高相容性，透明质酸表面在心血管植入（如支架和血管移植物）中的应用日益增多，加上人们对抗衰老产品的认识不断提高，这些因素推动了该行业的发展。

透明质酸类真皮填充剂的有效性和显着效果正吸引着这个群体。此外，新冠疫情改变了许多行业的动态，出行限制、保持社交距离以及对实践的重新审视成为「新常态」。随着美容行业逐步恢復运营，许多医生表示，美容手术的咨询量显着增加。此外，隔离也促使专业人士使用视讯会议设备，让人们更重视自己的形象。在某些情况下，人们选择接受美容疗程。这被称为“Zoom热潮”或“Zoom效应”。

受疫情影响，全球整形外科医师的患者数量显着增加，尤其是在美国、澳洲和日本等国家。 2022年，北美占据了最大的收入份额。儘管价格昂贵，但患者更倾向于短期治疗方法，以及骨关节炎等目标疾病的流行是其高份额的主要因素。 2022年，北美地区最赚钱的产品应用是用于治疗骨关节炎的真皮填充剂和黏性补充剂。预计亚太地区在预测期内的复合年增长率将最快。

中国和日本的老年人口不断增长，为抗衰老产品和服务提供了庞大的基本客群。人们对产品用途和功效的认识不断提高，也推动了需求的成长。此外，可支配所得水准的提高也进一步推动了该地区的扩张。欧洲在过去两年中发生了显着的变化。不断增长的需求导致新参与企业的价格竞争加剧。世界卫生组织最近公布了英国和德国的肥胖症流行。老化人口成长与肥胖之间的关係是欧洲区域产业的潜在驱动力。

透明质酸市场报告重点

  • 真皮填充剂领域将占据市场主导地位，到 2024 年将占据 41.82% 的最大收益占有率。
  • 北美将主导市场，到 2024 年将占据 42.08% 的份额。透明质酸市场的发展受到抗衰老治疗需求的增加、骨关节炎患者数量的增加以及对微创手术认识的不断提高的推动。
  • 美国透明质酸市场正在经历强劲增长，这得益于非手术美容程序的需求不断增长以及医疗应用的进步，特别是基于透明质酸的真皮填充剂。
  • 预计预测期内亚太地区透明质酸市场将以 8.25% 的复合年增长率成长…

目录

第一章调查方法与范围

第二章执行摘要

第三章透明质酸市场变数、趋势与范围

  • 市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章透明质酸市场：用途预测与趋势分析

  • 2024 年及 2030 年各应用领域的市场占有率
  • 应用程式细分仪表板
  • 市场规模、预测与趋势分析（按应用，2018-2030 年）
    • 真皮填充剂
    • 骨关节炎
    • 眼科
    • 膀胱输尿管逆流症

第五章透明质酸市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 市场规模、预测趋势分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各国情况
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第六章 竞争态势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 战略地图
  • 公司简介/列表
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals
    • Seikagaku Corporation
    • F. Hoffmann-La Roche Ag
    • Galderma Laboratories LP
    • Zimmer Biomet
    • Smith &Nephew Plc
    • Ferring BV
    • Lifecore Biomedical, Llc
    • HTL Biotechnology
    • Shiseido Company, Limited
    • Bloomage Biotechnology Corporation Limited
    • LG Life Sciences Ltd（LG Chem.）
    • Maruha Nichiro, Inc.
Product Code: 978-1-68038-333-1

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.7 billion by 2030, registering a CAGR of 7.81% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

  • The dermal fillers segment dominated the market and obtained the largest revenue share of 41.82% in 2024.
  • North America dominated the market and accounted for 42.08% share in 2024. The hyaluronic acid market is driven by increasing demand for anti-aging treatments, rising osteoarthritis cases, and growing awareness of minimally invasive procedures.
  • The U.S. hyaluronic acid market is experiencing robust growth, driven by increasing demand for non-surgical aesthetic procedures and advancements in medical applications, particularly hyaluronic acid-based dermal fillers.
  • APAC hyaluronic acid market is anticipated grow with a CAGR of 8.25% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, By Application, 2018 to 2030
    • 4.3.1. Dermal fillers
      • 4.3.1.1. Dermal fillers Market 2018 - 2030 (USD Million)
    • 4.3.2. Osteoarthritis
      • 4.3.2.1. Osteoarthritis Market 2018 to 2030 (USD Million)
      • 4.3.2.2. Single-injection
        • 4.4.2.2.1 Single injection Market 2018 to 2030 (USD Million)
      • 4.3.2.3. Three-injection
        • 4.4.2.3.1. Three injection Market 2018 to 2030 (USD Million)
      • 4.3.2.4. Five-injection
        • 4.4.2.3.1. Five injection Market 2018 to 2030 (USD Million)
    • 4.4.3. Ophthalmic
      • 4.4.3.3. Ophthalmic Market 2018 to 2030 (USD Million)
    • 4.4.4. Vesicoureteral reflux
      • 4.4.2.3. Vesicoureteral reflux Market 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.5.1. North America Hyaluronic Acid Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. U.S. Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Canada Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Mexico Hyaluronic Acid market 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Reimbursement Framework
      • 5.5.2.4. UK Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Reimbursement Framework
      • 5.5.3.4. Germany Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Reimbursement Framework
      • 5.5.4.4. France Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Reimbursement Framework
      • 5.5.5.4. Italy Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Reimbursement Framework
      • 5.5.6.4. Spain Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Denmark
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Reimbursement Framework
      • 5.5.7.4. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Sweden
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Reimbursement Framework
      • 5.5.8.4. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Norway
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Reimbursement Framework
      • 5.5.9.4. Norway Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Reimbursement Framework
      • 5.6.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Reimbursement Framework
      • 5.6.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Reimbursement Framework
      • 5.6.4.4. India Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Reimbursement Framework
      • 5.6.5.4. Australia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. South Korea
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Reimbursement Framework
      • 5.6.6.4. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Reimbursement Framework
      • 5.6.7.4. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Reimbursement Framework
      • 5.7.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Reimbursement Framework
      • 5.7.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Reimbursement Framework
      • 5.8.2.4. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Reimbursement Framework
      • 5.8.3.4. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Reimbursement Framework
      • 5.8.4.4. UAE Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Reimbursement Framework
      • 5.8.5.4. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listings
    • 6.5.1. Allergan
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Sanofi
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Genzyme Corporation
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Anika Therapeutics, Inc.
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Salix Pharmaceuticals
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Seikagaku Corporation
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. F. Hoffmann-La Roche Ag
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Galderma Laboratories L.P.
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Zimmer Biomet
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Smith & Nephew Plc
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Ferring B.V.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Lifecore Biomedical, Llc
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. HTL Biotechnology
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Shiseido Company, Limited
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Bloomage Biotechnology Corporation Limited
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. LG Life Sciences Ltd (LG Chem.)
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Maruha Nichiro, Inc.
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hyaluronic acid market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 14 France hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 18 Denmark hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 19 Sweden hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 23 China hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 24 India hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 25 Australia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 28 Latin America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Docetaxel market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait hyaluronic acid market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hyaluronic Acid market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hyaluronic Acid market dynamics
  • Fig. 12 Hyaluronic Acid market: Porter's five forces analysis
  • Fig. 13 Hyaluronic Acid market: PESTLE analysis
  • Fig. 14 Product market, 2018 - 2030 (USD Million)
  • Fig. 15 Dermal fillers market, 2018 - 2030 (USD Million)
  • Fig. 16 Osteoarthritis market, 2018 - 2030 (USD Million)
  • Fig. 17 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 18 Vesicoureteral reflux market, 2018 - 2030 (USD Million)
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 North America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. country dynamics
  • Fig. 22 U.S. hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada country dynamics
  • Fig. 24 Canada hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico country dynamics
  • Fig. 26 Mexico hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 28 UK country dynamics
  • Fig. 29 UK hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany country dynamics
  • Fig. 31 Germany hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 32 France country dynamics
  • Fig. 33 France hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy country dynamics
  • Fig. 35 Italy hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain country dynamics
  • Fig. 37 Spain hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 38 Norway country dynamics
  • Fig. 39 Norway hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden country dynamics
  • Fig. 41 Sweden hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark country dynamics
  • Fig. 43 Denmark hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan country dynamics
  • Fig. 46 Japan hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 47 China country dynamics
  • Fig. 48 China hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 49 India country dynamics
  • Fig. 50 India hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia country dynamics
  • Fig. 52 Australia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea country dynamics
  • Fig. 54 South Korea hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand country dynamics
  • Fig. 56 Thailand hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil country dynamics
  • Fig. 59 Brazil hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina country dynamics
  • Fig. 61 Argentina hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa country dynamics
  • Fig. 64 South Africa hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia country dynamics
  • Fig. 66 Saudi Arabia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 67 UAE country dynamics
  • Fig. 68 UAE hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait country dynamics
  • Fig. 70 Kuwait hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 71 Company categorization
  • Fig. 72 Company market position analysis
  • Fig. 73 Strategic framework